Cancer glossary
Stable disease on a CT report: what it means and is it good news
Stable disease (SD) means the tumor neither shrank enough for a partial response nor grew enough for progression. How RECIST 1.1 defines it and why it counts.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026
In short
Stable disease (SD) is a response category in which the tumor has not shrunk enough to count as a partial response and has not grown enough to count as progression. It does not mean “nothing changed”; it means “any change stayed within the corridor”.
How it appears in your report
- “Stable disease” or “stable appearance”.
- “No significant change compared with the scan of …”.
- “RECIST 1.1 response: stable disease (SD)”.
- In an oncologist’s letter: “stable disease on treatment”.
“No change” always refers to one particular earlier scan, so check which one it was compared with.
What it means
Under RECIST 1.1, stable disease is everything that does not fit the other categories:
| Change in the sum of target lesion diameters | Category |
|---|---|
| Down by 30% or more from baseline | Partial response |
| A smaller decrease, no change, or growth below the progression threshold | Stable disease |
| Up by 20% or more from the smallest sum (and at least 5 mm), or a new lesion | Progression |
So “stable disease” can hide a small decrease or a small increase. That is why it helps to look not only at the label in the report but at the actual measurements over time. PET-CT has its own equivalent, “stable metabolic disease”, under the criteria for metabolic response.
Does it affect treatment
With many kinds of drug treatment, stable disease is an expected result, and the current treatment is usually continued if it is tolerated. Duration matters too: stable disease that lasts many months shows the cancer is being controlled. If the goal is to shrink the tumor before surgery, your doctor may see stable disease differently. The decision is made by your treating doctor or a tumor board. If you are not sure what your report means, I can go through it in a consultation.
Questions to ask your doctor
- What were the lesion sizes at the start of treatment, and what are they now?
- Given the goal of my treatment, is stable disease a good enough result?
- When is the next scan, and where should it be done so results are comparable?
Sources
- RECIST 1.1 — RECIST Working Group / EORTC; Eisenhauer E.A. et al., European Journal of Cancer, 2009
- Response evaluation criteria in solid tumours (RECIST) — Radiopaedia
- PET Response Criteria in Solid Tumors (PERCIST) — Radiopaedia
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
